Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 99401-99450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04610866
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat
PHASE1/PHASE2Active, not recruiting
15 participants
Started: Dec 9, 2020 · Completed: Feb 28, 2028
2 conditions1 sponsor1 location
NCT04622540
EBD RCT Trial in Living Donor Liver Transplantation
NARecruiting
124 participants
Started: Dec 9, 2020 · Completed: Nov 30, 2026
4 conditions1 sponsor1 location
NCT04485559
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
PHASE1Recruiting
50 participants
Started: Dec 9, 2020 · Completed: Dec 31, 2027
3 conditions4 sponsors18 locations
NCT04480502
ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma
PHASE2Active, not recruiting
207 participants
Started: Dec 9, 2020 · Completed: Oct 31, 2024
2 conditions1 sponsor30 locations
NCT04725474
First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER)
PHASE1/PHASE2Active, not recruiting
274 participants
Started: Dec 9, 2020 · Completed: Oct 31, 2027
1 condition1 sponsor13 locations
NCT04707729
ROX Index for the Timing of Intubation in Nasal High Flow
NARecruiting
630 participants
Started: Dec 9, 2020 · Completed: Jun 30, 2025
1 condition1 sponsor12 locations
NCT04504071
Dacomitinib in Lung Cancer With Uncommon EGFR Mutations
PHASE2Active, not recruiting
30 participants
Started: Dec 8, 2020 · Completed: Dec 1, 2027
2 conditions1 sponsor1 location
NCT04651530
Endoscopic Cyclophotocoagulation in Normal Tension Glaucoma
NARecruiting
100 participants
Started: Dec 8, 2020 · Completed: Dec 1, 2026
2 conditions1 sponsor1 location
NCT04343313
The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study
NARecruiting
30 participants
Started: Dec 8, 2020 · Completed: Dec 31, 2029
1 condition1 sponsor5 locations
NCT04362644
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
PHASE1Recruiting
10 participants
Started: Dec 8, 2020 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06258551
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
N/ARecruiting
1,000 participants
Started: Dec 8, 2020 · Completed: Jun 30, 2026
8 conditions7 sponsors2 locations
NCT04378790
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
PHASE3Recruiting
544 participants
Started: Dec 8, 2020 · Completed: May 31, 2028
1 condition3 sponsors66 locations
NCT05020002
Extracellular RNA Biomarkers of Myotonic Dystrophy
N/ARecruiting
215 participants
Started: Dec 8, 2020 · Completed: Dec 31, 2025
1 condition4 sponsors3 locations
NCT04600089
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
PHASE2Recruiting
30 participants
Started: Dec 8, 2020 · Completed: Aug 31, 2027
3 conditions1 sponsor1 location
NCT03783572
Upper-limb Active Function and Botulinum Toxin a
NARecruiting
80 participants
Started: Dec 8, 2020 · Completed: Dec 30, 2027
3 conditions1 sponsor1 location
NCT04471844
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM
NAActive, not recruiting
981 participants
Started: Dec 8, 2020 · Completed: Jan 30, 2026
1 condition1 sponsor133 locations
NCT04590326
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
PHASE1/PHASE2Recruiting
612 participants
Started: Dec 8, 2020 · Completed: Nov 30, 2027
4 conditions1 sponsor24 locations
NCT04427826
Efficacy of Morphine in Reducing the Rate of Early Non-Invasive Ventilation Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Phase I/IIa
PHASE1/PHASE2Recruiting
24 participants
Started: Dec 8, 2020 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT04655976
Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy
PHASE3Active, not recruiting
758 participants
Started: Dec 8, 2020 · Completed: Mar 30, 2027
1 condition1 sponsor163 locations
NCT04656496
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
NARecruiting
520 participants
Started: Dec 8, 2020 · Completed: Nov 30, 2025
3 conditions2 sponsors10 locations
NCT04624204
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
PHASE3Active, not recruiting
672 participants
Started: Dec 8, 2020 · Completed: Oct 28, 2027
1 condition1 sponsor187 locations
NCT04219800
Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)
NAActive, not recruiting
142 participants
Started: Dec 8, 2020 · Completed: Dec 30, 2024
1 condition8 sponsors6 locations
NCT04328337
Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism
PHASE1/PHASE2Recruiting
40 participants
Started: Dec 8, 2020 · Completed: Jun 1, 2026
1 condition2 sponsors2 locations
NCT03813290
A Neuro-Technological Intervention for Adolescents With GAD
NARecruiting
30 participants
Started: Dec 8, 2020 · Completed: Jan 31, 2026
1 condition4 sponsors1 location
NCT04621370
A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer
PHASE2Not yet recruiting
48 participants
Started: Dec 7, 2020 · Completed: Dec 31, 2025
3 conditions4 sponsors0 locations
NCT02396459
Triac Trial II in MCT8 Deficiency Patients
PHASE2Active, not recruiting
22 participants
Started: Dec 7, 2020 · Completed: Jun 30, 2026
1 condition2 sponsors5 locations
NCT04458038
Does Chronic Obstructive Lung Disease Influence the Cognitive Function
NAActive, not recruiting
102 participants
Started: Dec 7, 2020 · Completed: Dec 31, 2023
1 condition4 sponsors1 location
NCT04819516
Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal Cancer
PHASE1Recruiting
10 participants
Started: Dec 7, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04715958
Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer
PHASE2/PHASE3Recruiting
200 participants
Started: Dec 7, 2020 · Completed: May 31, 2026
2 conditions2 sponsors3 locations
NCT04513444
Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy
PHASE2Recruiting
45 participants
Started: Dec 7, 2020 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT04530032
Ketogenic Diet & Functional Recovery in Moderate to Severe Traumatic Brain Injury
NAEnrolling by invitation
30 participants
Started: Dec 7, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04666636
Mechanisms for Activation of Beige Adipose Tissue in Humans
PHASE2Recruiting
65 participants
Started: Dec 7, 2020 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05084768
Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection
N/ARecruiting
150 participants
Started: Dec 7, 2020 · Completed: Oct 1, 2026
2 conditions1 sponsor1 location
NCT04668872
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
N/ARecruiting
30 participants
Started: Dec 7, 2020 · Completed: Dec 7, 2025
6 conditions1 sponsor1 location
NCT04414111
Highly Suppressive Treg in Delayed and Slow Graft Function After Kidney Transplantation
N/AActive, not recruiting
180 participants
Started: Dec 7, 2020 · Completed: Jul 31, 2025
2 conditions2 sponsors2 locations
NCT04401917
Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy Controls
EARLY_PHASE1Recruiting
60 participants
Started: Dec 7, 2020 · Completed: Dec 7, 2026
2 conditions1 sponsor1 location
NCT04658862
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
PHASE3Active, not recruiting
518 participants
Started: Dec 7, 2020 · Completed: Dec 31, 2028
1 condition1 sponsor290 locations
NCT04089358
Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study
PHASE3Active, not recruiting
384 participants
Started: Dec 7, 2020 · Completed: Dec 31, 2025
2 conditions3 sponsors116 locations
NCT04348045
Maintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status.
PHASE2Active, not recruiting
307 participants
Started: Dec 7, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors29 locations
NCT04933331
Early Caries Lesion Management Observational Study
N/AActive, not recruiting
744 participants
Started: Dec 7, 2020 · Completed: Mar 31, 2024
5 conditions1 sponsor4 locations
NCT04454528
BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy
PHASE1/PHASE2Recruiting
27 participants
Started: Dec 7, 2020 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT06211218
Artificial Intelligence for Screening of Multiple Corneal Diseases
N/ARecruiting
3,000 participants
Started: Dec 6, 2020 · Completed: Dec 6, 2024
3 conditions1 sponsor1 location
NCT06379334
Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population
N/AActive, not recruiting
180 participants
Started: Dec 6, 2020 · Completed: Dec 6, 2026
2 conditions1 sponsor1 location
NCT04454008
RCT of EF Family Training for P ADHD
NARecruiting
100 participants
Started: Dec 6, 2020 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06081803
Evolocumab in STEMI
PHASE3Active, not recruiting
166 participants
Started: Dec 5, 2020 · Completed: Dec 31, 2025
1 condition6 sponsors1 location
NCT04622319
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)
PHASE3Active, not recruiting
1,600 participants
Started: Dec 4, 2020 · Completed: Dec 31, 2030
2 conditions5 sponsors481 locations
NCT04474158
Creating Peace: Community-based Youth Violence Prevention to Address Racism and Discrimination
NAActive, not recruiting
1,800 participants
Started: Dec 4, 2020 · Completed: Jan 31, 2026
8 conditions3 sponsors1 location
NCT04358393
A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
PHASE1/PHASE2Recruiting
69 participants
Started: Dec 4, 2020 · Completed: Dec 30, 2025
7 conditions1 sponsor8 locations
NCT04510051
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
PHASE1Recruiting
18 participants
Started: Dec 4, 2020 · Completed: Feb 10, 2026
3 conditions2 sponsors3 locations
NCT04424303
Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis
N/ARecruiting
280 participants
Started: Dec 4, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor38 locations